Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03LNN
|
|||
| Former ID |
DCL000538
|
|||
| Drug Name |
IDX136
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Preclinical | [1] | |
| Company |
Idenix
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Herpes simplex virus DNA polymerase UL30 (HSV UL30) | Target Info | Inhibitor | [2], [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800042373) | |||
| REF 2 | Therapy with amineptine, a dopamine reuptake inhibitor, in patients with major depression. Indian J Psychiatry. 1997 Apr;39(2):147-53. | |||
| REF 3 | Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic. News for Idenix. 2008. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.